Cetera Investment Advisers
AVDL

Cetera Investment Advisers’s Avadel Pharmaceuticals AVDL Stock Holding History

Cetera Investment Advisers’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,673
Closed -$208K – 4808
2025
Q4 		$208K Sell
9,673
-106,536
-92% -$2.07M ﹤0.01% 4206
2025
Q3 		$1.77M Buy
116,209
+1,829
+2% +$23.8K ﹤0.01% 2281
2025
Q2 		$1.01M Buy
114,380
+9,815
+9% +$86.2K ﹤0.01% 2360
2025
Q1 		$819K Buy
104,565
+12,603
+14% +$106K ﹤0.01% 2428
2024
Q4 		$967K Sell
91,962
-24,747
-21% -$301K ﹤0.01% 2180
2024
Q3 		$1.53M Buy
116,709
+8,922
+8% +$136K ﹤0.01% 1800
2024
Q2 		$1.52M Sell
107,787
-6,191
-5% -$101K ﹤0.01% 1784
2024
Q1 		$1.93M Buy
+113,978
New +$1.7M ﹤0.01% 1575

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Cetera Investment Advisers's AVDL Position: Q1 2026 in Review

Cetera Investment Advisers sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 9,673 shares — an estimated $208K sold.

Cetera Investment Advisers first reported a position in AVDL in Q1 2024 and held it in 8 quarters. The position peaked at $1.93M in Q1 2024. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • Cetera Investment Advisers reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Cetera Investment Advisers sold 9,673 Avadel Pharmaceuticals shares in Q1 2026, an estimated $208K.
  • Cetera Investment Advisers first reported a position in Avadel Pharmaceuticals in Q1 2024 and held it in 8 quarters.
  • Cetera Investment Advisers's Avadel Pharmaceuticals position peaked at $1.93M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.